Related Experiment Videos
[Study on DNA polymerase beta gene mutation in human cervical cancer]
Li-ping Han1, Yu-huan Qiao, Zi-ming Dong
1Department of Obstetrics and Gynecology, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhonghua Fu Chan Ke Za Zhi
|January 20, 2004
Summary
DNA polymerase beta (POLB) gene mutations were found in cervical cancer (CC) tissues. These POLB mutations are linked to CC development and may cause increased mutation accumulation in tumor cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer (CC) is a significant global health concern.
- The role of specific gene mutations in CC pathogenesis requires further investigation.
Purpose of the Study:
- To determine the presence of DNA polymerase beta (POLB) gene mutations in human cervical cancer.
- To explore the association between POLB mutations and the histological differentiation of cervical cancer.
Main Methods:
- Analysis of fresh cervical cancer specimens (n=34) using reverse transcription polymerase chain reaction (RT-PCR).
- Mutation detection via single-strand conformation polymorphism (SSCP) analysis and DNA sequencing.
- Classification of specimens based on histological grade: Grade I (G1), Grade II (G2), and Grade III (G3).
Main Results:
- POLB gene mutations were identified in cervical cancer tissues.
- A significant correlation was observed between POLB mutation rates and histological differentiation (P < 0.05), with higher rates in poorly differentiated tumors.
- Sequencing revealed a specific A to G substitution at nucleotide 660, leading to an arginine to glycine amino acid change at codon 182.
Conclusions:
- POLB mutations are present in cervical cancer tissues and may contribute to CC development.
- These mutations appear to impair the catalytic activity of POLB.
- Impaired POLB function could result in the accumulation of mutations within tumor cells, promoting cancer progression.